Associated Papers
Impact of pharmacogenetics on aspirin resistance: a systematic review.
Silva GFD et al.
Arquivos De Neuro-psiquiatria, 2023
PON1 Q192R genotype influences clopidogrel responsiveness by relative platelet inhibition instead of on-treatment platelet reactivity.
Li X et al.
Thrombosis Research, 2013
Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction.
Verschuren JJ et al.
International Journal of Cardiology, 2013
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis.
Reny JL et al.
Journal of Thrombosis and Haemostasis : Jth, 2012
Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction.
Simon T et al.
Clinical Pharmacology and Therapeutics, 2011
Paraoxonase-1 is a major determinant of clopidogrel efficacy.
Bouman HJ et al.
Nature Medicine, 2011
Interaction between PON1 and population density in amyotrophic lateral sclerosis.
Diekstra FP et al.
Neuroreport, 2009
Select a paper to view details